Literature DB >> 17519514

Papillary thyroid carcinoma in a patient with sarcoidosis treated with minocycline.

N A Bruins1, J E Oswald, H Morreau, J Kievit, S Pavel, A H M Smelt.   

Abstract

Long-term treatment with minocycline is occasionally associated with the development of black thyroid syndrome in which thyroid cancer is frequently found. Here, we report a patient with cutaneous, pulmonary and thyroid sarcoidosis who developed papillary thyroid carcinoma in the presence of a black thyroid syndrome after being treated with minocycline for 2.5 years.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17519514

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  6 in total

1.  Black thyroid.

Authors:  Darrin V Bann; Neerav Goyal; Henry Crist; David Goldenberg
Journal:  Ear Nose Throat J       Date:  2014 Oct-Nov       Impact factor: 1.697

2.  Concomitant sarcoidosis and papillary thyroid cancer with severe hypercalcaemia as the main symptom.

Authors:  Mikael Groth Riis; Kasper Svendsen Juhl; Jens Meldgaard Bruun
Journal:  BMJ Case Rep       Date:  2018-06-08

3.  Minocycline-induced skin pigmentation.

Authors:  Tetsuro Kobayashi; Kayoko Hayakawa
Journal:  Infection       Date:  2016-10-17       Impact factor: 3.553

4.  Novel Cause of 'Black Thyroid': Intraoperative Use of Indocyanine Green.

Authors:  Rebecca D Chernock; Ryan S Jackson
Journal:  Endocr Pathol       Date:  2017-09       Impact factor: 3.943

5.  Black thyroid associated with thyroid carcinoma.

Authors:  Emad Kandil; Mohamed Abdel Khalek; Haytham Alabbas; Philip Daroca; Tina Thethi; Paul Friedlander; Ryan Leblanc; Obai Abdullah; Bernard Jaffe; Byron Crawford
Journal:  Int J Endocrinol       Date:  2010-11-23       Impact factor: 3.257

6.  The diagnostic challenge of coexistent sarcoidosis and thyroid cancer - a retrospective study.

Authors:  Vera Wenter; Nathalie L Albert; Freba Ahmaddy; Marcus Unterrainer; Julia Hornung; Harun Ilhan; Peter Bartenstein; Christine Spitzweg; Nikolaus Kneidinger; Andrei Todica
Journal:  BMC Cancer       Date:  2021-02-07       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.